Anthropometric Measures and Severity of Gastroesophageal Reflux Disease | NCT01954667 | Trialant
CompletedObservationalUpdated Oct 7, 2013
Anthropometric Measures and Severity of Gastroesophageal Reflux Disease
ClinicalTrials.gov ID
NCT01954667
Lead Sponsor
Ain Shams UniversityOTHER
Overall Status
Completed
Study Type
Observational
Enrollment
80Actual
Last Update Posted
Oct 7, 2013Estimated
Start Date
Jan 2012
Primary Completion Date
Aug 2013Actual
Completion Date
Aug 2013Actual
Brief Summary
evaluate the impact of different anthropometric measures on clinical and endoscopic severity of GERD and its relation to serum leptin.
Gastroesophageal Reflux Disease
No interventions
There are no interventions for this study.
Ages Eligible for Study
Adult (18-64)Older Adult (65+)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
Gastro esophageal reflux symptoms (e.g. heart burn, regurgitation, water brash or atypical symptoms such as hoarseness of voice, asthma and cough)
complete upper gastrointestinal endoscopy.
Exclusion Criteria:
Receiving medication for reflux disease (including proton pump inhibitor, histamine type 2 receptors blocker, prokinetic agents) in the previous month.
Pregnant woman.
History of upper abdominal surgery.
Severe co-morbidity as cirrhosis, end-stage renal disease and heart failure.